Our results showed that the expression of YAP1 gene, as well as its target genes (AMOTL2, CYR61, CTGF, MYC, GLI2, and AXL) increased significantly in the poor prognostic group of IBC patients (Fig. S2E, p < 0.01). The gene discussed is CCN1; the disease is inflammatory breast carcinoma.